102 related articles for article (PubMed ID: 35748021)
1. The state of PSA counseling in male-to-female transgender patients in the U.S.
Marthi S; O'Rourke TK; Tucci C; Pareek G; Hyams E
Prostate; 2022 Oct; 82(14):1315-1321. PubMed ID: 35748021
[TBL] [Abstract][Full Text] [Related]
2. Prostate Cancer Screening Uptake in Transgender Women.
Kalavacherla S; Riviere P; Kalavacherla S; Anger JT; Murphy JD; Rose BS
JAMA Netw Open; 2024 Feb; 7(2):e2356088. PubMed ID: 38353948
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer screening in transgender patients: findings from the 2014 BRFSS survey.
Narayan A; Lebron-Zapata L; Morris E
Breast Cancer Res Treat; 2017 Dec; 166(3):875-879. PubMed ID: 28828563
[TBL] [Abstract][Full Text] [Related]
4. Comparing Smokeless Tobacco Use between Male-to-Female and Female-to-Male Transgender Adults in the United States.
Tundealao S; Titiloye T
Subst Use Misuse; 2023; 58(11):1343-1349. PubMed ID: 37243498
[No Abstract] [Full Text] [Related]
5. Impact of Sexual Orientation Identity on Medical Morbidities in Male-to-Female Transgender Patients.
Gaither TW; Awad MA; Osterberg EC; Romero A; Bowers ML; Breyer BN
LGBT Health; 2017 Feb; 4(1):11-16. PubMed ID: 28005497
[TBL] [Abstract][Full Text] [Related]
6. Gender and Frequent Mental Distress: Comparing Transgender and Non-Transgender Individuals' Self-Rated Mental Health.
Crissman HP; Stroumsa D; Kobernik EK; Berger MB
J Womens Health (Larchmt); 2019 Feb; 28(2):143-151. PubMed ID: 30615547
[TBL] [Abstract][Full Text] [Related]
7. Laboratory-confirmed HIV and sexually transmitted infection seropositivity and risk behavior among sexually active transgender patients at an adolescent and young adult urban community health center.
Reisner SL; Vetters R; White JM; Cohen EL; LeClerc M; Zaslow S; Wolfrum S; Mimiaga MJ
AIDS Care; 2015; 27(8):1031-6. PubMed ID: 25790139
[TBL] [Abstract][Full Text] [Related]
8. The State of Prescreening Discussions About Prostate-specific Antigen Testing Following Implementation of the 2012 United States Preventive Services Task Force Statement.
Turini GA; Gjelsvik A; Renzulli JF
Urology; 2017 Jun; 104():122-130. PubMed ID: 28322897
[TBL] [Abstract][Full Text] [Related]
9. Breast and Cervical Cancer Screening Disparities in Transgender People.
Oladeru OT; Ma SJ; Miccio JA; Wang K; Attwood K; Singh AK; Haas-Kogan DA; Neira PM
Am J Clin Oncol; 2022 Mar; 45(3):116-121. PubMed ID: 35195561
[TBL] [Abstract][Full Text] [Related]
10. Mental health of transgender youth in care at an adolescent urban community health center: a matched retrospective cohort study.
Reisner SL; Vetters R; Leclerc M; Zaslow S; Wolfrum S; Shumer D; Mimiaga MJ
J Adolesc Health; 2015 Mar; 56(3):274-9. PubMed ID: 25577670
[TBL] [Abstract][Full Text] [Related]
11. Lung Cancer Screening Eligibility and Utilization Among Transgender Patients: An Analysis of the 2017-2018 United States Behavioral Risk Factor Surveillance System Survey.
Stowell JT; Parikh Y; Tilson K; Narayan AK
Nicotine Tob Res; 2020 Dec; 22(12):2164-2169. PubMed ID: 32623455
[TBL] [Abstract][Full Text] [Related]
12. Using a two-step method to measure transgender identity in Latin America/the Caribbean, Portugal, and Spain.
Reisner SL; Biello K; Rosenberger JG; Austin SB; Haneuse S; Perez-Brumer A; Novak DS; Mimiaga MJ
Arch Sex Behav; 2014 Nov; 43(8):1503-14. PubMed ID: 25030120
[TBL] [Abstract][Full Text] [Related]
13. Samoan Men's Sexual Attraction and Viewing Time Response to Male-to-Feminine Transgender and Cisgender Adults.
Petterson LJ; Vasey PL
Arch Sex Behav; 2021 Apr; 50(3):873-884. PubMed ID: 33492521
[TBL] [Abstract][Full Text] [Related]
14. Viral hepatitis screening in transgender patients undergoing gender identity hormonal therapy.
Mangla N; Mamun R; Weisberg IS
Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1215-1218. PubMed ID: 28857896
[TBL] [Abstract][Full Text] [Related]
15. Disparities in Prostate Cancer Screening for Transgender Women: An Analysis of the MarketScan Database.
Premo H; Gordee A; Lee HJ; Scales CD; Moul JW; Peterson A
Urology; 2023 Jun; 176():237-242. PubMed ID: 36972765
[TBL] [Abstract][Full Text] [Related]
16. Measuring the Health of an Invisible Population: Lessons from the Colorado Transgender Health Survey.
Christian R; Mellies AA; Bui AG; Lee R; Kattari L; Gray C
J Gen Intern Med; 2018 Oct; 33(10):1654-1660. PubMed ID: 29761263
[TBL] [Abstract][Full Text] [Related]
17. Patterns in prostate-specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002-2006.
Ross LE; Taylor YJ; Richardson LC; Howard DL
J Natl Med Assoc; 2009 Apr; 101(4):316-24. PubMed ID: 19397221
[TBL] [Abstract][Full Text] [Related]
18. Self-Reported Changes in Attractions and Social Determinants of Mental Health in Transgender Adults.
Katz-Wise SL; Reisner SL; White Hughto JM; Budge SL
Arch Sex Behav; 2017 Jul; 46(5):1425-1439. PubMed ID: 27542082
[TBL] [Abstract][Full Text] [Related]
19. Misclassification of Sex Assigned at Birth in the Behavioral Risk Factor Surveillance System and Transgender Reproductive Health: A Quantitative Bias Analysis.
Tordoff D; Andrasik M; Hajat A
Epidemiology; 2019 Sep; 30(5):669-678. PubMed ID: 31162292
[TBL] [Abstract][Full Text] [Related]
20. Substance use and treatment of substance use disorders in a community sample of transgender adults.
Keuroghlian AS; Reisner SL; White JM; Weiss RD
Drug Alcohol Depend; 2015 Jul; 152():139-46. PubMed ID: 25953644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]